Sleep disorders in Parkinson's disease

McDonald, 2003, Prevalence, etiology, and treatment of depression in Parkinson's disease, Biol Psychiatry, 54, 363, 10.1016/S0006-3223(03)00530-4 Chokroverty, 1996, Sleep and degenerative neurologic disorders, Neurol Clin., 14, 807, 10.1016/S0733-8619(05)70286-3 Garcia-Borreguero, 2003, Parkinson's disease and sleep, Sleep Med Rev., 7, 115, 10.1053/smrv.2002.0229 Oerlemans, 2002, The prevalence of sleep disorders in patients with Parkinson's disease: A self-reported, community-based survey, Sleep Med., 3, 147, 10.1016/S1389-9457(01)00127-7 Scaravilli, 2003, Health-related quality of life and sleep disorders in Parkinson's disease, Neurol Sci., 24, 209, 10.1007/s10072-003-0134-y Shochat, 2001, Sleep disorders in the elderly, Curr Treat Options Neurol., 3, 19, 10.1007/s11940-001-0021-x Autret, 2001, Sleep and brain lesions: A critical review of the literature and additional new cases, Neurophysiol Clin., 31, 356, 10.1016/S0987-7053(01)00282-9 Lai, 2003, Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder, Mol Neurobiol., 27, 137, 10.1385/MN:27:2:137 Larsen, 2001, Sleep disorders in patients with Parkinson's disease: Epidemiology and management, CNS Drugs, 15, 267, 10.2165/00023210-200115040-00002 Rye, 2002, Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD, Neurology, 58, 341, 10.1212/WNL.58.3.341 Cantor, 2002, Dopamine agonists and sleep in Parkinson's disease, Neurology, 58, S71, 10.1212/WNL.58.suppl_1.S71 Trenkwalder, 1998, Sleep dysfunction in Parkinson's disease, Clin Neurosci., 5, 107 Kumar, 2002, Sleep disorders in Parkinson's disease, Mov Disord., 17, 775, 10.1002/mds.10167 Rye, 2003, Sleepiness and unintended sleep in Parkinson's disease, Curr Treat Options Neurol., 5, 231, 10.1007/s11940-003-0014-z Hess, 1997, Sleep disorders and dementia, Schweiz Rundsch Med Prax, 86, 1343 Ganguli, 1996, Prevalence and persistence of sleep complaints in a rural older community sample: The MoVIES project, J Am Geriatr Soc, 44, 778, 10.1111/j.1532-5415.1996.tb03733.x Avidan, 2003, Insomnia in the geriatric patient, Clin Cornerstone, 5, 51, 10.1016/S1098-3597(03)90035-4 Schafer, 2000, Effects of parkinsonian medication on sleep, J Neurol, 247, IV24, 10.1007/PL00007770 Pollak, 2000, Other symptoms of advanced stage Parkinson's disease, Rev Neurol (Paris), 156, 165 Zesiewicz, 2003, Sleep attacks and dopamine agonists for Parkinson's disease: What is currentlyknown?, CNS Drugs, 17, 593, 10.2165/00023210-200317080-00004 Caap-Ahlgren, 2001, Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An inter view study of patients living at home, Arch Gerontol Geriatr, 32, 23, 10.1016/S0167-4943(00)00087-X Karlsen, 2000, Health related quality of life in Parkinson's disease: A prospective longitudinal study, J Neurol Neurosurg Psychiatry, 69, 584, 10.1136/jnnp.69.5.584 Valldeoriola, 1999, Therapy of behavioral disorders in Parkinson's disease, Biomed Pharmacother, 53, 149, 10.1016/S0753-3322(99)80081-X Merino-Andreu, 2003, Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness, Neurology, 60, 1553, 10.1212/01.WNL.0000058905.71369.97 Comella, 2003, Sleep episodes in Parkinson's disease: More questions remain, Sleep Med, 4, 267, 10.1016/S1389-9457(03)00116-3 Brodsky, 2003, Sleepiness in Parkinson's disease: A controlled study, Mov Disord, 18, 668, 10.1002/mds.10429 Kumar, 2003, Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS), Sleep Med, 4, 339, 10.1016/S1389-9457(03)00105-9 Roth, 2003, Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists, Sleep Med, 4, 275, 10.1016/S1389-9457(03)00058-3 Chaudhuri, 2001, Restless legs syndrome, J Neurol Neurosurg Psychiatry, 71, 143, 10.1136/jnnp.71.2.143 Gagnon, 2002, REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease, Neurology, 59, 585, 10.1212/WNL.59.4.585 Comella, 1998, Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease, Neurology, 51, 526, 10.1212/WNL.51.2.526 Iranzo, 2002, The importance of sleep medicine consultation for diagnosis of REM sleep behavior disorder in most patients with Parkinson's disease, Sleep Med, 3, 537, 10.1016/S1389-9457(02)00172-7 Neven, 1998, The prevalence of clinically significant sleep apnoea syndrome in The Netherlands, Thorax, 53, 638, 10.1136/thx.53.8.638 Arnulf, 2001, Respiratory disorders during sleep in degenerative diseases of the brain stem, Rev Neurol (Paris), 157, S148 Johns, 1991, A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale, Sleep, 14, 540, 10.1093/sleep/14.6.540 Ancoli-Israel, 1997, Use of wrist activity for monitoring sleep/wake in demented nursing-home patients, Sleep, 20, 24, 10.1093/sleep/20.1.24 Smith, 2003, Cognitive behavior therapy for chronic insomnia, Clin Cornerstone, 5, 28, 10.1016/S1098-3597(03)90033-0 Spielman, 1987, Treatment of chronic insomnia by restriction of time in bed, Sleep, 10, 45 Bootzin, 1972, Stimulus control treatment for insomnia, 395 Kleitman, 1939 Engle-Friedman, 1992, An evaluation of behavioral treatments for insomnia in the older adult, J Clin Psychol, 48, 77, 10.1002/1097-4679(199201)48:1<77::AID-JCLP2270480112>3.0.CO;2-J Chung, 2003, Systematic review of antidepressant therapies in Parkinson's disease, Parkinsonism Relat Disord, 10, 59, 10.1016/S1353-8020(03)00108-1 Geroldi, 1997, Drug treatment in Lewy body dementia, Dement Geriatr Cogn Disord, 8, 188, 10.1159/000106630 Jankovic, 2001, Dystonia and parkinsonism, Parkinsonism Relat Disord, 8, 109, 10.1016/S1353-8020(01)00025-6 Olson, 1997, Gapapentin for parkinsonism: A double-blind, placebo-controlled, crossover trial, Am J Med., 102, 60, 10.1016/S0002-9343(96)00381-6 Garcia-Borreguero, 2002, Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study, Neurology, 59, 1573, 10.1212/WNL.59.10.1573 Hajak, 1998, Safety and tolerance of zolpidem in the treatment of disturbed sleep: A postmarketing surveillance of 16,944 cases, Int Clin Psychopharmacol, 13, 157, 10.1097/00004850-199807000-00002 Daniele, 1997, Zolpidem in Parkinson's disease, Lancet, 349, 1222, 10.1016/S0140-6736(05)62416-6 Lavoisy, 1997, Zolpidem in Parkinson's disease, Lancet, 350, 74, 10.1016/S0140-6736(05)66285-X Wang, 2001, Zolpidem use and hip fractures in older people, J Am Geriatr Soc, 49, 1685, 10.1111/j.1532-5415.2001.49280.x Fernandez, 2003, Treatment of psychosis in Parkinson's disease: Safety considerations, Drug Saf, 26, 643, 10.2165/00002018-200326090-00004 Boeve, 2003, Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: Results in 14 patients, Sleep Med, 4, 281, 10.1016/S1389-9457(03)00072-8 Hogl, 2003, The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease, Neuropsychopharmacology, 28, 1866, 10.1038/sj.npp.1300250 Trenkwalder, 2004, Ropinirole in the treatment of restless legs syndrome: Results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries, J Neurol Neurosurg Psychiatry, 75, 92 Hogl, 2002, Modafinil for the treatment of daytime sleepiness in Parkinson's disease: A double-blind, randomized, crossover, placebo-controlled polygraphic trial, Sleep, 25, 905, 10.1093/sleep/25.8.62 DeBattista, 2004, A prospective trial of modafmil as an adjunctive treatment of major depression, J Clin Psychopharmacol, 24, 87, 10.1097/01.jcp.0000104910.75206.b9